Method and kit for diagnosing or controlling the treatment of breast cancer
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jan 20, 2005
app pub date -
Jul 19, 2004
filing date -
Sep 6, 2001
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The present invention pertains to a procedure and a kit for the diagnosis or monitoring of breast cancer in humans. This procedure is based on the feature that one recognizes the presence or absence in a human blood sample of at least two different mRNAs that code for various members of the tumor marker proteins EGF-R, CEA, stanniocalcin, CK20, MAGE-3, GA733.2, MUC1, Her-2/neu, claudin-7, and/or PDGF-.beta., and a conclusion is drawn from this in regard to the presence of mammary carcinoma cells in the blood sample, and thus in regard to possible metastasis.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully